A center for sharing data and resources to improve cancer treatment
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
This study is all about bringing researchers together to find better ways to treat cancer by understanding how tumors fight back against treatments, so patients can benefit from new combination therapies and improved monitoring methods.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-10558158 on NIH RePORTER |
What this research studies
This research focuses on enhancing cancer treatment by creating a centralized hub for data management and resource sharing among researchers. It aims to understand how tumors resist therapies and identify ways to exploit their vulnerabilities. By fostering collaboration among a multidisciplinary team, the project will evaluate combination therapies and develop real-time monitoring methods to improve patient outcomes. Patients may benefit from the insights gained through this collaborative effort, which seeks to advance the effectiveness of anti-cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of cancer who may benefit from innovative combination therapies.
Not a fit: Patients with non-malignant conditions or those not currently undergoing cancer treatment may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and improved patient outcomes.
How similar studies have performed: Previous research has shown success in collaborative approaches to cancer treatment, indicating that this strategy has the potential for meaningful advancements.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.